BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 35178984)

  • 1. [Active constituents of Urtica fissa in inhibition of benign prostatic hyperplasia].
    Zhang H; Chen Y; Li XB; Deng WX; Wang MY
    Zhongguo Zhong Yao Za Zhi; 2022 Jan; 47(2):419-427. PubMed ID: 35178984
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemical constituents from
    Zhang Y; Liu J; Guo Z; Li X; Wang M
    Nat Prod Res; 2021 Sep; 35(18):3011-3017. PubMed ID: 31674849
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Lignans with inhibitory effect on 5α-reductase from Urtica cannabina].
    Chen Y; Guo ZX; Li XB; Sun CJ; Wang MY
    Zhongguo Zhong Yao Za Zhi; 2021 Aug; 46(15):3846-3852. PubMed ID: 34472258
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of spontaneous canine benign prostatic hyperplasia by an Urtica fissa polysaccharide fraction.
    Xiaocheng C; Shan H; Yuxing L; Lizhen Y; Linmao D; Shoujun Y; Qinglin Z
    Planta Med; 2015 Jan; 81(1):10-4. PubMed ID: 25473922
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the therapeutic effect against benign prostatic hyperplasia and the active constituents from Epilobium angustifolium L.
    Deng L; Zong W; Tao X; Liu S; Feng Z; Lin Y; Liao Z; Chen M
    J Ethnopharmacol; 2019 Mar; 232():1-10. PubMed ID: 30529422
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Two new secolignans from the roots of Urtica fissa.
    Lu X; Li XQ; Qin HH; Feng BM; Cheng XH; Yang QX; Yu DY; Shi LY; Yu ZX; Fang XX
    J Asian Nat Prod Res; 2019 Feb; 21(2):165-170. PubMed ID: 29224377
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemical constituents from branch of Fraxinus sieboldiana.
    Lin S; Zhang YL; Liu MT; Zi JC; Gan ML; Song WX; Fan XN; Wang XN; Yang YC; Shi JG
    Zhongguo Zhong Yao Za Zhi; 2015 Jul; 40(13):2602-11. PubMed ID: 26697686
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of 3, 4-divanillyltetrahydrofuran from Urtica fissa on sexual dysfunction in diabetic mice.
    Yang WJ; Ma YM; Gong P; Wang L; Chang XN; Liu M; Shuai ZR
    J Ethnopharmacol; 2022 May; 289():115060. PubMed ID: 35121049
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibitory Activities of Phenolic Compounds Isolated from Adina rubella Leaves Against 5α-Reductase Associated with Benign Prostatic Hypertrophy.
    Yin J; Heo JH; Hwang YJ; Le TT; Lee MW
    Molecules; 2016 Jul; 21(7):. PubMed ID: 27399661
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies on Chromatographic Fingerprint and Fingerprinting Profile-Efficacy Relationship of Saxifraga stolonifera Meerb.
    Wu XD; Chen HG; Zhou X; Huang Y; Hu EM; Jiang ZM; Zhao C; Gong XJ; Deng QF
    Molecules; 2015 Dec; 20(12):22781-98. PubMed ID: 26703540
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Uvaria rufa Blume attenuates benign prostatic hyperplasia via inhibiting 5α-reductase and enhancing antioxidant status.
    Buncharoen W; Saenphet K; Saenphet S; Thitaram C
    J Ethnopharmacol; 2016 Dec; 194():483-494. PubMed ID: 27732901
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Three new secolignan glycosides from Urtica fissa E. Pritz.
    Feng BM; Qin HH; Wang HG; Shi LY; Yu DY; Ji BQ; Zhao Q; Wang YQ
    J Nat Med; 2012 Jul; 66(3):562-5. PubMed ID: 22124934
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The chemical constituents from Urtica fissa leaves.
    Wang MY; Yang Y; Zhou XY; Wang SS; Duan SX; Li XB
    J Asian Nat Prod Res; 2018 Aug; 20(8):709-718. PubMed ID: 28971690
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of the polysaccharide fraction of Urtica fissa on castrated rat prostate hyperplasia induced by testosterone propionate.
    Zhang Q; Li L; Liu L; Li Y; Yuan L; Song L; Wu Z
    Phytomedicine; 2008 Sep; 15(9):722-7. PubMed ID: 18242969
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phytochemical, Chemotaxonomic and Bioinformatics Study on Laportea bulbifera (Urticaceae).
    Lu X; Zhao Y; Li B; Feng W; Qi J; Feng B
    Chem Biodivers; 2022 Jul; 19(7):e202200070. PubMed ID: 35620918
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Two new secolignans with in vitro anti-inflammatory activities from Urtica fissa rhizomes.
    Feng X; Wang M; Cheng J; Li X
    J Nat Med; 2017 Jul; 71(3):553-557. PubMed ID: 28243817
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serenoa repens extracts: In vitro study of the 5α-reductase activity in a co-culture model for Benign Prostatic Hyperplasia.
    Buonocore D; Verri M; Cattaneo L; Arnica S; Ghitti M; Dossena M
    Arch Ital Urol Androl; 2018 Sep; 90(3):199-202. PubMed ID: 30362688
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Effects of
    Kim NH; Jegal J; Kim YN; Heo JD; Rho JR; Yang MH; Jeong EJ
    Nutrients; 2020 May; 12(6):. PubMed ID: 32481550
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Further investigation into maple syrup yields 3 new lignans, a new phenylpropanoid, and 26 other phytochemicals.
    Li L; Seeram NP
    J Agric Food Chem; 2011 Jul; 59(14):7708-16. PubMed ID: 21675726
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Study on effect of extract from Tibetan medicine Urtica hyperborean on anti-prostatic hyperplasia].
    Su RN; Wei RR; Luo WZ; Zhu JX; Wang L; Zhong GY
    Zhongguo Zhong Yao Za Zhi; 2019 May; 44(9):1953-1959. PubMed ID: 31342726
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.